|1.||Montefiori, David C: 4 articles (01/2012 - 06/2002)|
|2.||Kraft, Zane: 3 articles (01/2012 - 06/2006)|
|3.||Stamatatos, Leonidas: 3 articles (01/2012 - 06/2006)|
|4.||Esteban, Mariano: 2 articles (01/2015 - 01/2015)|
|5.||Li, Yuxing: 2 articles (07/2014 - 04/2009)|
|6.||Bergmeier, Lesley A: 2 articles (07/2012 - 07/2011)|
|7.||Schuitemaker, Hanneke: 2 articles (07/2012 - 07/2011)|
|8.||Lehner, Thomas: 2 articles (07/2012 - 07/2011)|
|9.||Shao, Yiming: 2 articles (07/2012 - 06/2012)|
|10.||Schøller, Jørgen: 2 articles (07/2012 - 07/2011)|
07/01/2011 - "Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques."
07/01/2014 - "Accordingly, we used HIV envelope gp140 and CD4 or coreceptor (CoR) binding site (bs) mutant probes to evaluate HIV-specific responses in peripheral blood B cells of HIV-infected individuals at various stages of infection. "
07/01/2012 - "Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques."
07/01/2011 - "However, we also demonstrated an association between NK cell-mediated ADCC responses and the amount of SIVmac251 gp140 binding antibody that developed after viral infection. "
09/01/2006 - "Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection."
|2.||Colonic Neoplasms (Colon Cancer)
05/10/2008 - "Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques."
07/01/2010 - "Overall, the replicating Ad5hr-HIV/SIV priming/gp140 protein boosting approach elicited strong systemic and mucosal antibodies with multiple functional activities associated with control of both acute and chronic viremia."
11/01/2000 - "In addition, the two groups of cats immunized either with gp140 and IL-16 or with gp140 and the CpG had greatly reduced viremia. "
02/27/2012 - "A greater than two-log drop in RNA copies/ml at peak viremia and earlier set point was achieved in macaques primed with rDNA, and boosted with rMVA/SHIV-AE plus gp140. "
06/13/2012 - "Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunization."
06/01/2009 - "gp140, gp140dG, and gp140dV were transferred into plasmid vector and recombinant Tiantan vaccinia (rTTV) vector to generate three DNA vaccines and three rTTV vaccines for vaccination of female BALB/c mice in a prime-boost regimen. "
09/01/1997 - "Twelve monoclonal antibodies (MAbs), TB1 to TB12, were produced against a soluble vaccinia recombinant envelope glycoprotein (gp140) from simian immunodeficiency virus SIVmac251. "
01/01/2015 - "Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen."
06/13/2012 - "Codon-optimized gp140 and gp145 env genes derived from HIV-1(cn54), a CRF07 B'/C recombinant strain, were constructed as DNA and recombinant Tiantan vaccinia (rTV) vaccines. "
|5.||Acquired Immunodeficiency Syndrome (AIDS)
01/15/2015 - "Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles."
06/01/2002 - "Importantly, this modified Env, gp140 Delta CFI, stimulated the antibody response to native gp160 while it retained its ability to induce a CTL response, a desirable feature for an AIDS vaccine."
02/01/1988 - "T cells from individuals with certain autoimmune diseases (rheumatoid arthritis, graft-versus-host disease, acquired immunodeficiency syndrome) express high levels of a cell surface sialoglycoprotein with a molecular weight of 140 kDa (gp140). "
08/01/2011 - "The importance of the strength of antigen adsorption by aluminum-containing adjuvants on immunopotentiation was studied using HIV 1 SF162dV2gp140 (gp140), a potential HIV/AIDS antigen. "
|3.||Proteins (Proteins, Gene)
|7.||DNA (Deoxyribonucleic Acid)
|9.||Protein Subunits (Protein Subunit)